Advertisement
Screener

NEURAXIS, INC. (NRXS) Other Nonoperating Income (Expense)

2.8 / 5 stars · 68/120 Roast Me

NEURAXIS, INC. Other Nonoperating Income (Expense)

NEURAXIS, INC. (NRXS) reported Other Nonoperating Income (Expense) of $38.97 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Income Statement › Other Income

us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-11

  • NEURAXIS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $38.97K, a 42.00% increase year-over-year.
  • NEURAXIS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$20.75K, a 226.43% decline year-over-year.
  • NEURAXIS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $8.21K, a 56.06% decline year-over-year.
  • NEURAXIS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$22.71K.
  • NEURAXIS, INC. other nonoperating income (expense) for fiscal 2025 was $29.35K.
  • NEURAXIS, INC. other nonoperating income (expense) for fiscal 2024 was -$1.08M.
  • NEURAXIS, INC. other nonoperating income (expense) for fiscal 2023 was -$7.96M.
  • NEURAXIS, INC. other nonoperating income (expense) for fiscal 2022 was -$1.41M.
Period endOther Nonoperating Income (Expense) 3 monthOther Nonoperating Income (Expense) 3 month as first filedOther Nonoperating Income (Expense) 6 monthOther Nonoperating Income (Expense) 9 monthOther Nonoperating Income (Expense) 9 month as first filedOther Nonoperating Income (Expense) 12 month
2026-06-30$38.97K
10-Q · filed 2026-08-11
$18.21K
10-Q · filed 2026-08-11
$26.42K
derived: sum of 3 quarters · filed 2026-08-11
$3.71K
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31-$20.75K
10-Q · filed 2026-05-12
-$12.54K
derived: sum of 2 quarters · filed 2026-05-12
-$35.25K
derived: sum of 3 quarters · filed 2026-05-12
-$7.81K
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$8.21K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$14.50K
derived: sum of 2 quarters · filed 2026-03-19
$12.94K
derived: sum of 3 quarters · filed 2026-08-11
$29.35K
10-K · filed 2026-03-19
2025-09-30-$22.71K
10-Q · filed 2025-11-10
$4.73K
derived: sum of 2 quarters · filed 2026-08-11
$21.14K
10-Q · filed 2025-11-10
$39.83K
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$27.44K
10-Q · filed 2026-08-11
$43.85K
10-Q · filed 2026-08-11
$62.54K
derived: sum of 3 quarters · filed 2026-08-11
-$41.42K
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$16.41K
10-Q · filed 2026-05-12
$35.10K
derived: sum of 2 quarters · filed 2026-05-12
-$68.86K
derived: sum of 3 quarters · filed 2026-05-12
-$779.74K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$18.69K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$85.27K
derived: sum of 2 quarters · filed 2026-03-19
-$796.15K
derived: sum of 3 quarters · filed 2026-03-19
-$1.08M
10-K · filed 2026-03-19
2024-09-30-$103.96K
10-Q · filed 2025-11-10
-$814.84K
derived: sum of 2 quarters · filed 2025-11-10
-$1.10M
10-Q · filed 2025-11-10
-$1.07M
derived: sum of 4 quarters · filed 2025-11-10
2024-06-30-$710.88K
10-Q · filed 2025-08-12
-$999.41K
10-Q · filed 2025-08-12
-$968.50K
derived: sum of 3 quarters · filed 2025-08-12
-$6.57M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31-$288.53K
10-Q · filed 2025-05-12
-$257.62K
derived: sum of 2 quarters · filed 2025-05-12
-$5.86M
derived: sum of 3 quarters · filed 2025-05-12
-$6.98M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$30.91K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
-$5.57M
derived: sum of 2 quarters · filed 2025-03-20
-$6.69M
derived: sum of 3 quarters · filed 2025-03-20
-$7.96M
10-K · filed 2025-03-20
2023-09-30-$5.60M
10-Q · filed 2024-11-12
-$1.88M
10-Q · filed 2023-11-20
-$6.72M
derived: sum of 2 quarters · filed 2024-11-12
-$7.99M
10-Q · filed 2024-11-12
-$4.27M
10-Q · filed 2023-11-20
-$7.03M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$1.12M
10-Q · filed 2024-08-09
-$2.40M
10-Q · filed 2024-08-09
-$1.42M
derived: sum of 3 quarters · filed 2024-08-09
-$2.30M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31-$1.28M
10-Q · filed 2024-05-20
-$304.54K
derived: sum of 2 quarters · filed 2024-05-20
-$1.18M
derived: sum of 3 quarters · filed 2024-05-20
-$2.03M
derived: sum of 4 quarters · filed 2024-05-20
2022-12-31$972.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16
$96.04K
derived: sum of 2 quarters · filed 2024-04-16
-$750.91K
derived: sum of 3 quarters · filed 2024-04-16
-$1.41M
10-K · filed 2024-04-16
2022-09-30-$876.56K
10-Q · filed 2023-11-20
-$1.72M
derived: sum of 2 quarters · filed 2023-11-20
-$2.38M
10-Q · filed 2023-11-20
2022-06-30-$846.95K
10-Q · filed 2023-09-22
-$1.50M
10-Q · filed 2023-09-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
electroCore, Inc. (ECOR)United States$0.102B
Streamex Corp. (STEX)United States$0.089B-0.19
Vivani Medical, Inc. (VANI)United States$0.111B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B